A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in

Patricia Devaux1, Andrew W Hudacek, Gregory Hodge

  • 1Department of Molecular Medicine, Mayo Clinic and Foundation, Guggenheim 18-01B, 200 First Street SW, Rochester, MN 55905, USA. devaux.patricia@mayo.edu

Journal of Virology
|October 29, 2010
PubMed

Insights

Measles virus (MV) antagonizes immune function by controlling STAT1. A modified MV unable to block STAT1 showed reduced virulence in primates, indicating STAT1 interaction is key for MV disease.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Measles virus (MV) is a significant global child health threat due to its immune suppression.
  • The MV P gene produces P, V, and C proteins that disrupt innate immunity, targeting key regulators like STAT1.

Purpose of the Study:

  • To identify specific MV protein residues essential for STAT1 antagonism.
  • To generate a STAT1-blind MV and evaluate its virulence and immunogenicity in a primate model.

Main Methods:

  • Site-directed mutagenesis was used to create a recombinant MV (STAT1-blind MV) with altered P and V protein residues (Y110, V112, H115).
  • Rhesus monkeys were intranasally inoculated with either wild-type MV or STAT1-blind MV.
  • Viral load (viremia), clinical signs, inflammatory markers (IL-6, TNF-alpha), and adaptive immune responses (neutralizing antibodies, T-cells) were assessed.

Main Results:

  • STAT1-blind MV exhibited reduced viremia and absent clinical signs (rash) compared to wild-type MV.
  • The STAT1-blind virus showed less control over the inflammatory response, with increased IL-6 and TNF-alpha transcription.
  • Humoral and cellular immune responses were comparable between groups infected with wild-type and STAT1-blind MV.

Conclusions:

  • Efficient interaction between MV proteins (P/V) and STAT1 is crucial for sustaining viral virulence in natural hosts by modulating the inflammatory response.
  • Targeted modification of MV to create STAT1-blind strains could offer potential as novel vectors for oncolysis and vaccination.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...